Expert InterviewASND
Slingshot members are talking to an expert! The topic is:
A Second Look: Discussing the treatment landscape for hypoparathyroidism, including an overview of Ascendis' YORVIPATH (palopegteriparatide)
Executed on:Jan 20, 2026 4:00 PM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
Institution: UCLA
- Physician and Academic Researcher in Endocrinology, Metabolism, and Internal Medicine at UCLA.
- Currently manages over 500 patients with hypoparathyroidism.
- Research focuses on endocrine signals that mediate adipose-muscle crosstalk and identify molecular targets to prevent or reverse sarcopenia.
Interview Goal
This call will discuss the current treatment landscape for hypoparathyroidism and the potential of YORVIPATH (palopegteriparatide), recently approved by the FDA for the treatment of hypoparathyroidism in adults.